SK39396A3 - Emulsion agent - Google Patents

Emulsion agent Download PDF

Info

Publication number
SK39396A3
SK39396A3 SK393-96A SK39396A SK39396A3 SK 39396 A3 SK39396 A3 SK 39396A3 SK 39396 A SK39396 A SK 39396A SK 39396 A3 SK39396 A3 SK 39396A3
Authority
SK
Slovakia
Prior art keywords
emulsion
oil
surfactant
stabilizing
water
Prior art date
Application number
SK393-96A
Other languages
English (en)
Slovak (sk)
Inventor
Stefan Lundquist
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK39396A3 publication Critical patent/SK39396A3/sk

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
SK393-96A 1993-10-07 1994-10-05 Emulsion agent SK39396A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303281A SE9303281D0 (sv) 1993-10-07 1993-10-07 New formulation
PCT/SE1994/000926 WO1995009609A1 (en) 1993-10-07 1994-10-05 New emulsion formulation

Publications (1)

Publication Number Publication Date
SK39396A3 true SK39396A3 (en) 1997-02-05

Family

ID=20391342

Family Applications (1)

Application Number Title Priority Date Filing Date
SK393-96A SK39396A3 (en) 1993-10-07 1994-10-05 Emulsion agent

Country Status (31)

Country Link
US (2) US5843465A (et)
EP (1) EP0722316B1 (et)
JP (1) JPH09504279A (et)
CN (1) CN1134663A (et)
AT (1) ATE189119T1 (et)
AU (1) AU701512B2 (et)
BR (1) BR9407748A (et)
CA (1) CA2172143A1 (et)
CZ (1) CZ94396A3 (et)
DE (1) DE69422818T2 (et)
DK (1) DK0722316T3 (et)
EE (1) EE03235B1 (et)
EG (1) EG20540A (et)
ES (1) ES2145158T3 (et)
FI (1) FI961525A0 (et)
GR (1) GR3033255T3 (et)
HK (1) HK1009257A1 (et)
HU (1) HUT74638A (et)
IL (1) IL111131A (et)
IS (1) IS4209A (et)
MA (1) MA23344A1 (et)
NO (1) NO961363D0 (et)
NZ (1) NZ274583A (et)
PL (1) PL313767A1 (et)
PT (1) PT722316E (et)
SE (1) SE9303281D0 (et)
SG (1) SG47896A1 (et)
SK (1) SK39396A3 (et)
TN (1) TNSN94099A1 (et)
WO (1) WO1995009609A1 (et)
ZA (1) ZA947351B (et)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US20100184732A1 (en) * 2000-09-15 2010-07-22 Mcdonald George Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
DE10059430A1 (de) * 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
EP1401396A4 (en) 2001-06-15 2009-08-05 Cornerstone Pharmaceuticals PHARMACEUTICAL AND DIAGNOSTIC COMPOSITIONS WITH NANOPARTICLES FOR THE TREATMENT OF TARGET TISSUE AND CELLS
MXPA04001071A (es) * 2001-08-06 2004-05-20 Astrazeneca Ab Dispersion acuosa que comprende nanoparticulas estables de un activo insoluble en agua y un excipiente como trigliceridos de cadena media (mct).
TWI248159B (en) * 2002-01-25 2006-01-21 Nanya Technology Corp Manufacturing method for shallow trench isolation with high aspect ratio
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US20060135523A1 (en) * 2003-06-18 2006-06-22 Astrazeneca Ab 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
WO2005009406A1 (en) * 2003-07-18 2005-02-03 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition

Also Published As

Publication number Publication date
IS4209A (is) 1995-04-08
AU7866794A (en) 1995-05-01
ES2145158T3 (es) 2000-07-01
FI961525A (fi) 1996-04-04
PL313767A1 (en) 1996-07-22
US5660837A (en) 1997-08-26
CZ94396A3 (en) 1996-06-12
IL111131A (en) 1999-09-22
HU9600900D0 (en) 1996-05-28
SE9303281D0 (sv) 1993-10-07
GR3033255T3 (en) 2000-09-29
BR9407748A (pt) 1997-11-11
ZA947351B (en) 1995-04-10
SG47896A1 (en) 1998-04-17
WO1995009609A1 (en) 1995-04-13
NO961363L (no) 1996-04-02
DE69422818D1 (de) 2000-03-02
ATE189119T1 (de) 2000-02-15
AU701512B2 (en) 1999-01-28
DK0722316T3 (da) 2000-06-13
MA23344A1 (fr) 1995-07-01
NZ274583A (en) 1998-01-26
IL111131A0 (en) 1994-12-29
FI961525A0 (fi) 1996-04-04
HUT74638A (en) 1997-01-28
JPH09504279A (ja) 1997-04-28
TNSN94099A1 (fr) 1995-04-25
CA2172143A1 (en) 1995-04-13
CN1134663A (zh) 1996-10-30
EP0722316A1 (en) 1996-07-24
HK1009257A1 (en) 1999-05-28
EE03235B1 (et) 1999-12-15
DE69422818T2 (de) 2000-07-27
PT722316E (pt) 2000-06-30
EP0722316B1 (en) 2000-01-26
US5843465A (en) 1998-12-01
EG20540A (en) 1999-07-31
NO961363D0 (no) 1996-04-02

Similar Documents

Publication Publication Date Title
SK39396A3 (en) Emulsion agent
JP2022009013A (ja) 安定なニモジピン非経口製剤
SK76799A3 (en) An ibuprofen composition, a preparation in water drink's form containing ibuprofen and method for its preparation
US12016857B2 (en) Stable liquid vigabatrin pharmaceutical composition for oral dosage
WO2019186515A1 (en) Liquid pharmaceutical compositions of antiepileptic drugs
US5637317A (en) Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
US20180125782A1 (en) Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
CN105939705B (zh) 用于肠胃外给药的包含epa甘油三酯和dha甘油三酯的组合物
JP2017095510A (ja) 脳卒中損傷の低減に使用するための短時間作用型ジヒドロピリジン（クレビジピン）
US9801846B2 (en) Composition comprising EPA and DHA ethylester for parenteral administration
KR20190121752A (ko) 국소마취약 함유 산성 에멀션 조성물
EP0651994A1 (de) Flüssige orale Zubereitungen von fettlösliche Arzneimittel
JPH0692848A (ja) 糖尿病治療用乳剤
JPH05229941A (ja) フェノール誘導体を含有する注射用乳剤
US20230263747A1 (en) Solutions for oral dosage
DE3406837A1 (de) Arteriosklerose-arzneimittel und -prophylaktikum
US20200316043A1 (en) Pharmaceutical composition comprising clevidipine and process for preparation thereof
EP2228055A1 (en) Riluzole liquid emulsions